title: Evaluating technology for acquisition.
abstract: Cancer care consumes approximately 8% to 9% of all healthcare spending. The use of technology plays a key role in cancer, with both diagnostic and treatment implications, and technology is a large driver of healthcare spending. Understanding the role of technology and its integration in care may contribute to appropriate selection and utilization of technology, better decision making as to priorities in acquisition, and clinical cost efficiency.
authors.affiliation: HCA Inc, One Park Plaza II-4W, Nashville, TN 37203, USA. pat.stanfilledens@hcahealthcare.com
authors.forename: Pat Stanfill
authors.initials: PS
authors.lastname: Edens
authors.forename: Donna
authors.initials: D
authors.lastname: Weber
mesh_terms: D002201:Capital Expenditures; D003362:Cost-Benefit Analysis; D003659:Decision Making, Organizational; D006801:Humans; D007857:Leadership; D016522:Oncology Service, Hospital / Q000458:organization & administration*; D011682:Purchasing, Hospital / Q000191:economics / Q000458:organization & administration*; D018787:Radiation Oncology / Q000191:economics / Q000295:instrumentation*; D011873:Radiology Information Systems / Q000191:economics* / Q000295:instrumentation; D016634:Radiosurgery / Q000191:economics / Q000295:instrumentation; D012051:Reimbursement Mechanisms; D013673:Technology Assessment, Biomedical; D014481:United States